AU2012900286A0 - "Methods of treatment or prophylaxis" - Google Patents

"Methods of treatment or prophylaxis"

Info

Publication number
AU2012900286A0
AU2012900286A0 AU2012900286A AU2012900286A AU2012900286A0 AU 2012900286 A0 AU2012900286 A0 AU 2012900286A0 AU 2012900286 A AU2012900286 A AU 2012900286A AU 2012900286 A AU2012900286 A AU 2012900286A AU 2012900286 A0 AU2012900286 A0 AU 2012900286A0
Authority
AU
Australia
Prior art keywords
prophylaxis
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012900286A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spinifex Pharmaceuticals Pty Ltd
Original Assignee
Spinifex Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Spinifex Pharmaceuticals Pty Ltd filed Critical Spinifex Pharmaceuticals Pty Ltd
Publication of AU2012900286A0 publication Critical patent/AU2012900286A0/en
Priority to JP2014553581A priority Critical patent/JP6258867B2/en
Priority to CN201380016259.9A priority patent/CN104470903B/en
Priority to NZ627560A priority patent/NZ627560A/en
Priority to PL13741446T priority patent/PL2807153T3/en
Priority to US14/373,355 priority patent/US20150011565A1/en
Priority to AU2013202973A priority patent/AU2013202973C9/en
Priority to PCT/AU2013/000061 priority patent/WO2013110134A1/en
Priority to ES13741446T priority patent/ES2798289T3/en
Priority to EP13741446.2A priority patent/EP2807153B1/en
Priority to CA2861231A priority patent/CA2861231C/en
Priority to PT137414462T priority patent/PT2807153T/en
Priority to ZA2014/05255A priority patent/ZA201405255B/en
Priority to HK15102125.7A priority patent/HK1201533A1/en
Priority to US15/149,641 priority patent/US9708275B2/en
Priority to JP2017205744A priority patent/JP2018076297A/en
Abandoned legal-status Critical Current

Links

AU2012900286A 2012-01-25 2012-01-25 "Methods of treatment or prophylaxis" Abandoned AU2012900286A0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
PT137414462T PT2807153T (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
PCT/AU2013/000061 WO2013110134A1 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
ES13741446T ES2798289T3 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
NZ627560A NZ627560A (en) 2012-01-25 2013-01-25 Heterocyclic piperazine compounds and methods for their use
PL13741446T PL2807153T3 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
US14/373,355 US20150011565A1 (en) 2012-01-25 2013-01-25 Heterocyclic Compounds and Methods For Their Use
AU2013202973A AU2013202973C9 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
JP2014553581A JP6258867B2 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods of use thereof
CN201380016259.9A CN104470903B (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
EP13741446.2A EP2807153B1 (en) 2012-01-25 2013-01-25 Heterocyclic compounds and methods for their use
CA2861231A CA2861231C (en) 2012-01-25 2013-01-25 Substituted 1-acyl-piperazine and 1-acyl-perhydro-1,4-diazepine compounds and their use as angiotensin ii type 2 receptor antagonists
ZA2014/05255A ZA201405255B (en) 2012-01-25 2014-07-17 Heterocyclic compounds and methods for their use
HK15102125.7A HK1201533A1 (en) 2012-01-25 2015-03-03 Heterocyclic compounds and methods for their use
US15/149,641 US9708275B2 (en) 2012-01-25 2016-05-09 Heterocyclic compounds and methods for their use
JP2017205744A JP2018076297A (en) 2012-01-25 2017-10-25 Heterocyclic compounds and methods for their use

Publications (1)

Publication Number Publication Date
AU2012900286A0 true AU2012900286A0 (en) 2012-02-16

Family

ID=

Similar Documents

Publication Publication Date Title
HUE041553T2 (en) Methods and compositions for the treatment of monogenic diseases
EP2621499A4 (en) Methods for the treatment of allergic diseases
GB2511713B (en) Compositions for the treatment of bone fragility
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP2736528A4 (en) Compositions and methods for the treatment of hiv
HK1201042A1 (en) Compositions for the treatment of dry eye
EP3049070A4 (en) Compositions and methods for treatment and prophylaxis of gastrointestinal diseases
EP2967049A4 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP2654745A4 (en) Composition for the treatment of skin conditions
GB201506561D0 (en) Treatment of amblyopia
HUE063599T2 (en) Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy
EP2814491A4 (en) Formulations and methods for the treatment or prophylaxis of pre-mci and/or pre-alzheimer's conditions
AP2014007905A0 (en) Novel compounds for the treatment of dyslipidemia and related diseases
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP3082427A4 (en) Compositions and methods for treatment of glaucoma
HK1216721A1 (en) Uses and methods for the treatment of liver diseases or conditions
EP3082845A4 (en) Methods and compositions for treatment of peripheral neuropathies
HK1212619A1 (en) Method of treatment or prophylaxis of infections of the eye
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
ZA201408065B (en) Compositions and methods for the treatment of diabetes
EP2994156A4 (en) Compounds, compositions and methods for the treatment of diseases through inhibiting tgf- activity
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
AU2012900286A0 (en) "Methods of treatment or prophylaxis"
AU2012900285A0 (en) Methods of treatment or prophylaxis
AU2012900057A0 (en) Methods of treatment or prophylaxis